GB2424881B - Halophenyl derivatives of bisalkylfluorene - Google Patents

Halophenyl derivatives of bisalkylfluorene

Info

Publication number
GB2424881B
GB2424881B GB0606551A GB0606551A GB2424881B GB 2424881 B GB2424881 B GB 2424881B GB 0606551 A GB0606551 A GB 0606551A GB 0606551 A GB0606551 A GB 0606551A GB 2424881 B GB2424881 B GB 2424881B
Authority
GB
United Kingdom
Prior art keywords
bisalkylfluorene
halophenyl
derivatives
halophenyl derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0606551A
Other versions
GB2424881A (en
GB0606551D0 (en
Inventor
Mark John Goulding
Warren Duffy
Cecile Schott
Peer Kirsch
Alexander Hahn
Masayoshi Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of GB0606551D0 publication Critical patent/GB0606551D0/en
Publication of GB2424881A publication Critical patent/GB2424881A/en
Application granted granted Critical
Publication of GB2424881B publication Critical patent/GB2424881B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/02—Monocyclic aromatic halogenated hydrocarbons
    • C07C25/13—Monocyclic aromatic halogenated hydrocarbons containing fluorine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/32—Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • C09K19/44—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing compounds with benzene rings directly linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
GB0606551A 2005-04-07 2006-03-31 Halophenyl derivatives of bisalkylfluorene Expired - Fee Related GB2424881B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05007604 2005-04-07

Publications (3)

Publication Number Publication Date
GB0606551D0 GB0606551D0 (en) 2006-05-10
GB2424881A GB2424881A (en) 2006-10-11
GB2424881B true GB2424881B (en) 2010-11-24

Family

ID=36425036

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0606551A Expired - Fee Related GB2424881B (en) 2005-04-07 2006-03-31 Halophenyl derivatives of bisalkylfluorene

Country Status (1)

Country Link
GB (1) GB2424881B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329675B2 (en) 2006-10-10 2012-12-11 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8541581B2 (en) 2009-04-07 2013-09-24 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8546564B2 (en) 2009-04-07 2013-10-01 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8957049B2 (en) 2008-04-09 2015-02-17 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9034849B2 (en) 2010-02-03 2015-05-19 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102065904B1 (en) * 2012-12-07 2020-01-15 엘지디스플레이 주식회사 Organic light emitting diode device and liquid crystal type emitting material used for the same
CN103896853A (en) * 2012-12-27 2014-07-02 海洋王照明科技股份有限公司 Pyrimidinyl electron transport material and preparation method thereof, and organic electroluminescent device
US9917260B2 (en) 2013-08-23 2018-03-13 Basf Se Compounds with terminal heteroarylcyanovinylene groups and their use in organic solar cells
GB2525245A (en) * 2014-04-17 2015-10-21 Lomox Ltd Fluoroalkylfluorene derivatives
GB2545626A (en) 2015-10-16 2017-06-28 Lomox Ltd Cross-linkable charge transport materials
CN106083538B (en) * 2016-06-07 2019-05-28 阜阳欣奕华材料科技有限公司 A kind of compound, liquid-crystal composition and liquid crystal display
CN109251136B (en) * 2017-07-14 2022-01-18 阜阳欣奕华材料科技有限公司 Compound, liquid crystal composition and display device
SG11202001684PA (en) 2017-10-06 2020-03-30 Forma Therapeutics Inc Inhibiting ubiquitin specific peptidase 30
ES2945834T3 (en) 2018-10-05 2023-07-07 Forma Therapeutics Inc Fused pyrrolines that act as inhibitors of ubiquitin-specific protease 30 (USP30)
CN112175627B (en) * 2020-09-24 2022-04-15 北京科技大学 Preparation method of blue phase liquid crystal composite material containing fluorene core bending type compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203128A1 (en) * 2001-12-12 2003-10-30 Ryushi Shundo Fluorene derivatives and their polymers
US20050146263A1 (en) * 2003-09-25 2005-07-07 Kelly Stephen M. Lighting elements, devices and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203128A1 (en) * 2001-12-12 2003-10-30 Ryushi Shundo Fluorene derivatives and their polymers
US20050146263A1 (en) * 2003-09-25 2005-07-07 Kelly Stephen M. Lighting elements, devices and methods
WO2006058182A2 (en) * 2004-11-23 2006-06-01 Kelly Stephen M Lighting elements, devices and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chemistry of Materials, 2004, Vol. 16(24), pages 4928-4936 & Chemical Abstracts, abstr no 142:103030. *
Liquid Crystals, 2005, Vol. 32(10), pages 1251-1264 & Chemical Abstracts, abstr no 145:18139. *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329675B2 (en) 2006-10-10 2012-12-11 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8349814B2 (en) 2006-10-10 2013-01-08 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8629125B2 (en) 2006-10-10 2014-01-14 Infinty Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9108989B2 (en) 2006-10-10 2015-08-18 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8957049B2 (en) 2008-04-09 2015-02-17 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8541581B2 (en) 2009-04-07 2013-09-24 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8546564B2 (en) 2009-04-07 2013-10-01 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8802119B2 (en) 2009-04-07 2014-08-12 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8802064B2 (en) 2009-04-07 2014-08-12 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9034849B2 (en) 2010-02-03 2015-05-19 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors

Also Published As

Publication number Publication date
GB2424881A (en) 2006-10-11
GB0606551D0 (en) 2006-05-10

Similar Documents

Publication Publication Date Title
GB2424881B (en) Halophenyl derivatives of bisalkylfluorene
HUS2000022I1 (en) Tiglien-3-one derivatives
PT1802579E (en) Derivatives of 3-arylaminopyridine
EP1878727A4 (en) 2-aminoquinazoline derivatives
HK1129305A1 (en) Substituted 4-amino-pyrrolo-triazine derivatives 4--
ZA200707358B (en) 1-benzylindole-2-carboxamide derivatives
ZA200805411B (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
EP1940843A4 (en) Unsaturated heterocyclic derivatives
IL185688A0 (en) 39-desmethoxy derivatives of rapamycin
PL1954674T3 (en) New n-phenethylcarboxamide derivatives
ZA200802088B (en) 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
ZA200802421B (en) 1-Acyldihydropyrazol derivatives
IL185757A0 (en) Methods of decreasing calcifcation
ZA200804257B (en) Azaindole-2-carboxamide derivatives
IL192235A0 (en) Aryl-isoxazol-4-yl-imidazole derivatives
IL184841A0 (en) Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
HK1161122A1 (en) Use of 24-norudca 24-norudca
IL191138A0 (en) Pyrazoloisoquinoline derivatives
EP1931370A4 (en) Use of des-aspartate-angiotensin i
GB0511410D0 (en) Benzotrizepinone derivatives
ZA200706577B (en) Dihydroimidazothiazole derivatives
IL186143A0 (en) Pro-drugs of n-thiazol-2yl-benzamide derivatives
ZA200707966B (en) Pro-drugs of n-thiazol-2yl-benzamide derivatives
HUP0500461A3 (en) Pyperazine derivatives of alkyl-oxindoles

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120331